Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.460
-0.080 (-5.19%)
At close: Aug 1, 2025, 4:00 PM
1.450
-0.010 (-0.68%)
After-hours: Aug 1, 2025, 7:43 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $8.24 million as of August 1, 2025. Its market cap has decreased by -22.52% in one year.
Market Cap
8.24M
Enterprise Value
-7.65M
1-Year Change
-22.52%
Ranking
Category
Stock Price
1.46
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $8.24M, a decrease of -97.99%. That is a compound annual growth rate of -27.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 8.57M | -73.44% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | 86.15M | 123.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.18B |
| Johnson & Johnson | 400.99B |
| AbbVie | 349.64B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 235.87B |
| Novartis AG | 227.02B |
| Novo Nordisk | 221.96B |
| Abbott Laboratories | 221.64B |